OpenURL Connection Search

Select item for more details and to access through your institution.

Blending space and time to talk about cancer in extended reality.
Published in:
NPJ Digital Medicine, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s41746-024-01262-x
By:
- Robb, Tamsin J.;
- Liu, Yinan;
- Woodhouse, Braden;
- Windahl, Charlotta;
- Hurley, Daniel;
- McArthur, Grant;
- Fox, Stephen B.;
- Brown, Lisa;
- Guilford, Parry;
- Minhinnick, Alice;
- Jackson, Christopher;
- Blenkiron, Cherie;
- Parker, Kate;
- Henare, Kimiora;
- McColl, Rose;
- Haux, Bianca;
- Young, Nick;
- Boyle, Veronica;
- Cameron, Laird;
- Deva, Sanjeev
Publication type:
Article
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumors.
Published in:
CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 7, p. 867, doi. 10.1002/psp4.12799
By:
- He, Jimmy;
- Jackson, Christopher G. C. A.;
- Deva, Sanjeev;
- Hung, Tak;
- Clarke, Katriona;
- Segelov, Eva;
- Chao, Tsu‐Yi;
- Dai, Ming‐Shen;
- Yeh, Hsien‐Tang;
- Ma, Wen Wee;
- Kramer, Douglas;
- Chan, Wing‐Kai;
- Kwan, Rudolf;
- Cutler, David;
- Zhi, Jay
Publication type:
Article
Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study.
Published in:
2014
By:
- Jackson, Christopher Gca;
- Sharples, Katrina;
- Thompson, Paul I;
- O'Donnell, Anne;
- Robinson, Bridget Anne;
- Perez, David J;
- Adams, Jacqui;
- Isaacs, Richard;
- Deva, Sanjeev;
- Hinder, Victoria A;
- Findlay, Michael P;
- Jackson, Christopher G C A
Publication type:
journal article
Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study.
Published in:
BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-737
By:
- Jackson, Christopher G. C. A.;
- Sharples, Katrina;
- Thompson, Paul I.;
- O'Donnell, Anne;
- Robinson, Bridget Anne;
- Perez, David J.;
- Adams, Jacqui;
- Isaacs, Richard;
- Deva, Sanjeev;
- Hinder, Victoria A.;
- Findlay, Michael P.
Publication type:
Article
Mortality within 30 days of systemic anticancer therapy at a tertiary cancer centre: assessing the safety and quality of clinical care.
Published in:
2017
By:
- Wilson, Michelle;
- Weng Mak;
- Firth, Melissa;
- Deva, Sanjeev;
- Findlay, Michael;
- Mak, Weng
Publication type:
journal article
Real‐world outcomes of cisplatin, capecitabine, and gemcitabine with either epirubicin (PEXG) or docetaxel (PDXG) as first‐line palliative treatment in metastatic or unresectable locally advanced pancreatic adenocarcinoma.
Published in:
Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 5, p. e231, doi. 10.1111/ajco.13845
By:
- Hitchen, Nadia;
- Waldron, Nick R.;
- Deva, Sanjeev;
- Findlay, Michael;
- Lawrence, Benjamin
Publication type:
Article
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma.
Published in:
Gastric Cancer, 2022, v. 25, n. 5, p. 943, doi. 10.1007/s10120-022-01308-7
By:
- Lu, Zhihao;
- Yang, Silu;
- Luo, Xuerui;
- Shi, Yang;
- Lee, Jong-Seok;
- Deva, Sanjeev;
- Liu, Tianshu;
- Chao, Yee;
- Zhang, Yun;
- Huang, Ruiqi;
- Xu, Yaling;
- Shen, Zhirong;
- Shen, Lin
Publication type:
Article
Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study.
Published in:
British Journal of Clinical Pharmacology, 2021, v. 87, n. 12, p. 4670, doi. 10.1111/bcp.14886
By:
- Jackson, Christopher G. C. A.;
- Hung, Tak;
- Segelov, Eva;
- Barlow, Paula;
- Prenen, Hans;
- McLaren, Blair;
- Hung, Noelyn Anne;
- Clarke, Katriona;
- Chao, Tsu‐Yi;
- Dai, Ming‐Shen;
- Yeh, Hsien‐Tang;
- Cutler, David L.;
- Kramer, Douglas;
- He, Jimmy;
- Zhi, Jay;
- Chan, Wing‐Kai;
- Kwan, Rudolf;
- Deva, Sanjeev
Publication type:
Article

Found: 8